Form 4 for NAMS NewAmsterdam Pharma Co N.V.
Accepted 2024-02-21 00:00:00 ET · period of report 2024-02-13 · accession 0000950170-24-018045 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-02-21 | 2024-02-13 | NAMS | LANGE LOUIS G | Dir | P - Purchase | $19.00 | +5,000 | 24.9K | +25% | +$95.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2024-02-13 | P | A | 5,000 | $19.00 | 24,878 | I See Footnote | — | — | (F1) Represents ordinary shares acquired from the Company in an underwritten public offering. The ordinary shares acquired from the Company were placed into and are being held in a trust account for the benefit of the Reporting Person. |